Rocket Watch 01 - 02Dec2024This is an ideal candidate for a pump. Should happen sometime in December. Watch out.
Note: This is not a recommendation or investment advice, just a stock to watch. Do your own research.
QNRX trade ideas
QNRX longas you see in the chart QNRX broke through a triangle pattern. QNRS tested yesterday the pattern then closed by Doji also today opened higher than yesterday's close. this is a bullish signal and hopefully, we will see a big jump soon .all the other indicators are showing positive signals. what I have written only my personal opinion could be right and could be wrong and I am not advising you to buy or sell.
QNRX - Move for 10% off of $24? Based on the massive move we saw yesterday I am looking for a continuation play if not for longer term at least for the short term of intraday trading.. (Not financial Advice)
QNRX first FDA-approved treatment for Netherton SyndromeQuoin Pharmaceuticals (NASDAQ: QNRX ) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects 1 in every 200,000 people worldwide.
This month, QNRX Signed Multiple Exclusive Distribution Agreements for in various regions of the globe for its Lead Asset, QRX003, for Netherton Syndrome.
JMP Securities Initiated Coverage on Quoin Pharmaceuticals, Ltd. ( QNRX ) with a Market Outperform rating and a price target of 8usd.
QNRX is massively oversold having a bullish divergence chart formation and fundamentals that can skyrocket the price to 12 usd in my opinion!
Could be a Great buy opportunity at $1.91 today!
QNRX Market Outperform Price Target !!Yesterday, JMP Securities Initiated Coverage on Quoin Pharmaceuticals, Ltd. (QNRX) with a Market Outperform rating and a price target of 8usd.
Quoin Pharmaceuticals (NASDAQ: QNRX) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects 1 in every 200,000 people worldwide.
This month, QNRX Signed Multiple Exclusive Distribution Agreements for in various regions of the globe for its Lead Asset, QRX003, for Netherton Syndrome.
My price target is the 12usd resistance.
Quoin Pharmaceuticals also breaks the floor. QNRXAnd has been doing so in succession for some time. Looking for zigzag completion here. We just love small caps here for their phenomenal volatility.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
